Stephen Dowd
Corporate Officer/Principal en RALLYBIO CORPORATION .
Perfil
Stephen Dowd is currently the Head of Business Development at Rallybio Corp.
Prior to this, he worked as a Senior Director of Business Development at Kymab Ltd., a Team Leader at GSK Plc, and a Senior Business Development Manager at Arecor Ltd.
He holds an MBA from the University of Cambridge and a doctorate from the University of Dundee.
Cargos activos de Stephen Dowd
Empresas | Cargo | Inicio |
---|---|---|
RALLYBIO CORPORATION | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Stephen Dowd.
Empresas | Cargo | Fin |
---|---|---|
GSK PLC | Corporate Officer/Principal | - |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Formación de Stephen Dowd.
University of Cambridge | Masters Business Admin |
University Of Dundee | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
GSK PLC | Health Technology |
RALLYBIO CORPORATION | Health Technology |
Empresas privadas | 2 |
---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Stephen Dowd